Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2011

View Archived Issues

Crizotinib suppresses osteosarcoma and associated osteolytic/osteoblastic changes in vivo

Combination therapies including cediranib well tolerated in patients with gastric cancer

Parthenolide sensitizes osteosarcoma cells to radiation

Sonias tablet approved in Japan for type 2 diabetes

Febuxostat approved in Japan for gout

Longdaysin prolongs circadian rhythms in vitro and in vivo

New inhibitors of HCV NS5B identified at Vivalis

New inhibitors of heat shock protein HSP 90 presented

Mologen provides pipeline update

Chelsea Therapeutics reports data on Northera in neurogenic orthostatic hypotension

New inhibitors of hepatocyte growth factor receptor claimed

Florbetapir-PET imaging in patients with Alzheimer's disease

CHMP adopts positive opinion for Gilenya in relapsing-remitting MS

Vidaza approved in Japan for myelodysplastic syndromes

New prostanoid DP2 receptor antagonists discovered

Auris Medical advances phase IIb trial of AM-111 for acute sensorineural hearing loss

Pradaxa approved in Japan for prevention of stroke in atrial fibrillation

Novel beta-secretase 1 inhibitors developed at AstraZeneca

RiVax receives FDA orphan drug status for prevention of ricin intoxication

CHMP adopts final negative opinion for cladribine tablets in relapsing-remitting MS

CHMP recommends approval of Jevtana combination regimen for prostate cancer

CHMP decides against approval of Fampyra to improve walking in MS

CBLB-502 demonstrates direct anticancer effect in preclinical models

Romiplate IV injection approved in Japan for chronic ITP

Purdue Pharma launches Butrans transdermal system CIII in U.S. for chronic pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...